Arcturus Therapeutics Holdings Inc (ARCT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ARCT Annual Balance Sheets →
The balance sheet data below highlights changes in Arcturus Therapeutics Holdings Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent211.38
Cash & Short-term Investments211.00
Accounts receivable1.34
Other Current Assets4.16
Total Current Assets216.88
Equipment/Property/Plant Net6.08
Other Assets, Noncurrent22.45
Prepaid Expenses And Other Receivables4.16
Operating Lease Right Of Use Asset20.42
Restricted Cash Noncurrent2.03
Total Assets245.41
Liabilities
Accounts Payable, Current AC4.09
Accrued Liabilities, Current AC22.67
Deferred Revenue, Current DE7.61
Total Current Liabilities34.37
Long-term debt0.00
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent19.68
Operating Lease Liability Noncurrent19.68
Total Liabilities54.05
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock732.89
Retained Earnings / Accumulated Deficit-541.55
Other Equity0.00
Common Stockholder's Equity191.36
Total Stockholder's Equity191.36
Liabilities & Stockholder's Equity245.41
4 historic quarters locked

Sign in to unlock the full Arcturus Therapeutics Holdings Inc balance sheet history.

About Arcturus Therapeutics Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-338090

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.